Isracann Biosciences ISCNF Stock
Isracann Biosciences Price Chart
Isracann Biosciences ISCNF Financial and Trading Overview
| Isracann Biosciences stock price | 0.0000 USD |
| Previous Close | 0.03 USD |
| Open | 0.03 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.03 - 0.04 USD |
| 52 Week Range | 0.009 - 0.06 USD |
| Volume | 143.81K USD |
| Avg. Volume | 210.18K USD |
| Market Cap | 6.16M USD |
| Beta (5Y Monthly) | 0.021571 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ISCNF Valuation Measures
| Enterprise Value | 5.08M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 35 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.32 |
Trading Information
Isracann Biosciences Stock Price History
| Beta (5Y Monthly) | 0.021571 |
| 52-Week Change | -32.69% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.06 USD |
| 52 Week Low | 0.009 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.02 USD |
ISCNF Share Statistics
| Avg. Volume (3 month) | 210.18K USD |
| Avg. Daily Volume (10-Days) | 190.41K USD |
| Shares Outstanding | 175.99M |
| Float | 175.69M |
| Short Ratio | N/A |
| % Held by Insiders | 0.17% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2022 |
| Most Recent Quarter (mrq) | August 31, 2022 |
| Next Fiscal Year End | May 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -34.99% |
| Return on Equity (ttm) | -252.75% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -2188597 USD |
| Net Income Avi to Common (ttm) | -4540223 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 198.05K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.295 |
| Book Value Per Share (mrq) | 0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1475229 USD |
| Levered Free Cash Flow (ttm) | -567046 USD |
Profile of Isracann Biosciences
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 595 Burrard Street |
| ZIP | V7X 1L3 |
| Phone | 604-394-2551 |
| Website | https://www.isracann.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.
Q&A For Isracann Biosciences Stock
What is a current ISCNF stock price?
Isracann Biosciences ISCNF stock price today per share is 0.0000 USD.
How to purchase Isracann Biosciences stock?
You can buy ISCNF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Isracann Biosciences?
The stock symbol or ticker of Isracann Biosciences is ISCNF.
Which industry does the Isracann Biosciences company belong to?
The Isracann Biosciences industry is Drug Manufacturers-Specialty & Generic.
How many shares does Isracann Biosciences have in circulation?
The max supply of Isracann Biosciences shares is 0.
What is Isracann Biosciences Price to Earnings Ratio (PE Ratio)?
Isracann Biosciences PE Ratio is now.
What was Isracann Biosciences earnings per share over the trailing 12 months (TTM)?
Isracann Biosciences EPS is -0.02 USD over the trailing 12 months.
Which sector does the Isracann Biosciences company belong to?
The Isracann Biosciences sector is Healthcare.